智通财经APP获悉，9月7日至9日，优趣汇(02177)旗下加拿大保健食品Vanpearl携手"大分子实验室"开启 新加坡溯源专场再传捷报，实现总销售额突破400万元，销售数量超过8000瓶(1)，并在7日首发场持续 霸榜抖音保健食品带货榜TOP1，直播间流量与转化表现超高(2)。 备注： Vanpearl作为优趣汇重点孵化的加拿大保健食品品牌，其核心产品ERGO - VITALIS™基因胶囊，凝聚了 前沿科研智慧与创新成分，产品蕴含着修复DNA延缓衰老的专利配方，它能精准激活细胞本源的生命 因子，有效替换受损DNA基因片段，同时全方位保护DNA基因组稳定，从根本上提升细胞自我修复效 率与代谢效率，实现细胞DNA基因层面的抗衰老效果，堪称 "基因守护者"。 此次Vanpearl与大分子合作的新加坡溯源专场，不仅实现了流量与转化的双高表现，也进一步巩固了其 在高端保健品市场的品牌影响力。优趣汇也凭借着在供应链、品牌运营与跨境电商领域的整合能力，持 续推动自有品牌与国际科研资源对接。 (1)以上销售及数量数据取自9月7号-9月9号，数据来源于飞瓜 (2)9月7号基因胶囊新加坡研学专场首发8点-9点持续霸榜保健食品 ...

Core Viewpoint - The financial results of Youquhui (02177) for the first half of 2025 show a revenue of 580 million yuan and a net profit of 11.2 million yuan, indicating a "zero growth" situation. However, excluding non-recurring items and terminated brand collaborations, revenue increased by 2.5% year-on-year, and net profit remained stable. The gross margin improved by 4.6 percentage points to 34.6% [1] Group 1: "Subtraction" Strategy - Youquhui has been actively divesting low-margin brands and channels, which has led to a continuous improvement in profitability. The gross margin has shown a significant upward trend, increasing from 23.9% in 2022 to 34.6% in the first half of 2025 [2] - The company terminated collaborations with low-margin brands in the personal care and beauty sectors, as well as ceased operations in stagnant e-commerce businesses, indicating a strategic shift towards higher-margin products [2] - The rising gross margin trend is a key indicator of potential future improvements in other performance metrics, despite short-term fluctuations in revenue and net profit [2] Group 2: "Addition" Strategy in Health Sector - Youquhui has identified the health sector as a primary area for diversification, capitalizing on the growing demand for functional health foods. The health segment's revenue grew by 42.9% in the first half of 2025, driven by the strong performance of its proprietary brand Vanpearl, which generated 14 million yuan in revenue [3][4] - The successful launch of the ERGO-VITALIS™ capsule, which utilizes ergothioneine as a key ingredient, has validated the company's health product development model [3] - Youquhui is expanding its partnerships with established health brands, enhancing its market presence and brand influence in the health sector [3] Group 3: Future Growth Potential - The company's mid-year report reflects a strategic investment phase, with a clear long-term growth trajectory despite the absence of immediate steep growth in core financial metrics [5] - Youquhui plans to prioritize overseas expansion, particularly in Southeast Asia and North America, utilizing localized compliance and collaboration with local KOLs to enhance brand visibility and market penetration [6] - The company has shifted its funding strategy from seeking investments in technology companies to focusing on acquisitions and strategic partnerships in the health and beauty sectors, indicating a proactive approach to seizing growth opportunities [6]

智通财经APP讯，优趣汇控股(02177)公布2025年中期业绩，收入为约5.8亿元，净利润为1120万元，每 股基本收益0.07元。 2025年上半年，品牌运营服务方面，该集团主动对既存品牌与渠道结构进行优化：(i)主动优化低毛利率 的品牌与渠道，深化与核心品牌方的合作，持续拓展海外市场，为合作伙伴提供多元化全渠道服务;(ii) 通过提升供应链运营效率，增强价格竞争力，有效规避低价竞争风险;及(iii)本报告期内引入新的健康品 牌，贡献新增收入1250万元。2025年上半年，抖音、拼多多及海外业务收入占集团整体收入比重为 12.4%，较去年同期占比11.1%，增加1.3个百分点。 自有品牌方面，该集团精准把握市场趋势，推出含麦角硫因活性成分的加拿大抗衰老健康食品品牌 Vanpearl，成功打造明星单品ERGO-VITALIS™胶囊，在本报告期内该品牌实现销售收入1400万元，为 集团业绩提供了有力支撑。与此同时，集团持续深化在益生菌赛道的战略布局，与诺和新元旗下高端塬 研益生菌品牌普葆达成战略合作，该合作重点聚焦于国内注重肠道健康的高净值消费群体。凭借多元化 的产品组合，集团不断夯实在高端健康食品领域的竞争 ...